What is SIBN's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 0.87B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for SIBN?

P/E (TTM) is n/a and 52-week range is $11.48 to $21.89 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s SIBN figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for SIBN?

The company profile lists revenue (TTM) near $213M, net income (TTM) near $-1.46B, EPS (TTM) near $-0.33 when available from the market-data feed. Figures are informational and may lag live markets.

Where is SI-BONE Inc based, and what identifiers does Chartloom list?

The company context section lists headquarters in Santa Clara, California, US, 44.4M shares outstanding, ISIN US8257041090 when available from company profile and filing metadata.

SI-BONE Inc

$SIBN

Health Care · Health Care Equipment & Supplies

IR Run Scenarios

$19.37

+2.70%

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

SI-BONE, Inc. is a medical device company, which engages in the provision of a proprietary minimally invasive surgical implant system to fuse the sacroiliac joint for treatment of musculoskeletal disorders of the sacropelvic anatomy. The company is headquartered in Santa Clara, California and currently employs 376 full-time employees. The company went IPO on 2018-10-17. The firm specializes in minimally invasive surgical implant systems to address sacroiliac joint dysfunction as well as address unmet clinical needs in pelvic fixation and management of pelvic fractures. The firm's products include a series of patented titanium implants, and the instruments used to implant them, as well as implantable bone products. Its products include iFuse, iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite. Within the United States, iFuse, iFuse-3D and iFuse-TORQ have clearances for applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma. Its first-generation iFuse, a machined triangular titanium implant, has a triangular cross section that resists twisting or rotation of the implant. The firm's second generation iFuse product, the iFuse-3D implant, is a patented titanium implant.

Employees

376

Website

si-bone.com/

IPO

2018-10-17

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)